These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29402990)

  • 1. Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia.
    Chandramouli C; Reichelt ME; Curl CL; Varma U; Bienvenu LA; Koutsifeli P; Raaijmakers AJA; De Blasio MJ; Qin CX; Jenkins AJ; Ritchie RH; Mellor KM; Delbridge LMD
    Sci Rep; 2018 Feb; 8(1):2346. PubMed ID: 29402990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition.
    Cohen CD; De Blasio MJ; Lee MKS; Farrugia GE; Prakoso D; Krstevski C; Deo M; Donner DG; Kiriazis H; Flynn MC; Gaynor TL; Murphy AJ; Drummond GR; Pinto AR; Ritchie RH
    Cardiovasc Diabetol; 2021 Jun; 20(1):116. PubMed ID: 34074290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy.
    Velagic A; Li M; Deo M; Li JC; Kiriazis H; Donner DG; Anderson D; De Blasio MJ; Woodman OL; Kemp-Harper BK; Qin CX; Ritchie RH
    Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H241-H257. PubMed ID: 36607798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
    Prakoso D; De Blasio MJ; Qin C; Rosli S; Kiriazis H; Qian H; Du XJ; Weeks KL; Gregorevic P; McMullen JR; Ritchie RH
    Clin Sci (Lond); 2017 Jun; 131(12):1345-1360. PubMed ID: 28487469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with crocin improves cardiac dysfunction by normalizing autophagy and inhibiting apoptosis in STZ-induced diabetic cardiomyopathy.
    Feidantsis K; Mellidis K; Galatou E; Sinakos Z; Lazou A
    Nutr Metab Cardiovasc Dis; 2018 Sep; 28(9):952-961. PubMed ID: 30017436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine restores autophagy and cardiac dysfunction in rats with streptozotocin-induced diabetes mellitus.
    Oh JE; Jun JH; Hwang HJ; Shin EJ; Oh YJ; Choi YS
    Acta Diabetol; 2019 Jan; 56(1):105-114. PubMed ID: 30206697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise training prevents the development of cardiac dysfunction in the low-dose streptozotocin diabetic rats fed a high-fat diet.
    Epp RA; Susser SE; Morissette MP; Kehler DS; Jassal DS; Duhamel TA
    Can J Physiol Pharmacol; 2013 Jan; 91(1):80-9. PubMed ID: 23369057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats.
    Bollano E; Omerovic E; Svensson H; Waagstein F; Fu M
    Int J Cardiol; 2007 Jan; 114(2):195-201. PubMed ID: 21882490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of exercise training on cardiac matrix metalloproteinases activity and cardiac function in mice with diabetic cardiomyopathy.
    Dede E; Liapis D; Davos C; Katsimpoulas M; Varela A; Mpotis I; Kostomitsopoulos N; Kadoglou NPE
    Biochem Biophys Res Commun; 2022 Jan; 586():8-13. PubMed ID: 34818584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial remodeling in diabetic cardiomyopathy associated with cardiac mast cell activation.
    Huang ZG; Jin Q; Fan M; Cong XL; Han SF; Gao H; Shan Y
    PLoS One; 2013; 8(3):e60827. PubMed ID: 23556005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cardiac inflammation and remodeling during the development of streptozotocin-induced diabetic cardiomyopathy in vivo: a time course analysis.
    Becher PM; Lindner D; Fröhlich M; Savvatis K; Westermann D; Tschöpe C
    Int J Mol Med; 2013 Jul; 32(1):158-64. PubMed ID: 23652584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI).
    Yu X; Tesiram YA; Towner RA; Abbott A; Patterson E; Huang S; Garrett MW; Chandrasekaran S; Matsuzaki S; Szweda LI; Gordon BE; Kem DC
    Cardiovasc Diabetol; 2007 Feb; 6():6. PubMed ID: 17309798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing equivalent diabetes in male and female Nos3-deficient mice results in a comparable onset of diabetic kidney injury.
    Tian L; Nikolic-Paterson DJ; Tesch GH
    Physiol Rep; 2019 Sep; 7(18):e14197. PubMed ID: 31535473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin IV attenuates diabetic cardiomyopathy
    Zhang M; Sui W; Xing Y; Cheng J; Cheng C; Xue F; Zhang J; Wang X; Zhang C; Hao P; Zhang Y
    Theranostics; 2021; 11(18):8624-8639. PubMed ID: 34522203
    [No Abstract]   [Full Text] [Related]  

  • 17. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy.
    Mano Y; Anzai T; Kaneko H; Nagatomo Y; Nagai T; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
    Circ J; 2011; 75(7):1717-27. PubMed ID: 21519150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy.
    Fricovsky ES; Suarez J; Ihm SH; Scott BT; Suarez-Ramirez JA; Banerjee I; Torres-Gonzalez M; Wang H; Ellrott I; Maya-Ramos L; Villarreal F; Dillmann WH
    Am J Physiol Regul Integr Comp Physiol; 2012 Oct; 303(7):R689-99. PubMed ID: 22874425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
    Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
    Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes.
    Gao X; Xu Y; Xu B; Liu Y; Cai J; Liu HM; Lei S; Zhong YQ; Irwin MG; Xia Z
    Diabetes Metab Res Rev; 2012 Jul; 28(5):409-17. PubMed ID: 22389139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.